Sechat - Notícias sobre a cannabis medicinal e cânhamo industrial

The proposal by Deputy Paulinha (Podemos) aims to regulate the scientific use of the plant and strengthen the health policy in the State

An analysis of the compounds that shape the flavor, aroma, and effects of the plant, focusing on the national scenario

Entrepreneur Fabrício Penafiel considers the inclusion of practical experience of producers in the proposal, with a deadline set for September 30th, a historic opportunity.

Understand cannabidiol, its functioning in the body, and potential therapeutic benefits

Understand everything about cannabidiol

With applications ranging from the pharmaceutical industry to construction, the sector is being structured with machinery, research, and investments, and is expected to grow even before the definitive regulation of cultivation in Brazil; the consultant discussed the topic during an interview at Andav 2025

Initiative aims to strengthen science, support public policies, and foster collaborations in the cannabis sector

RF-2 grants safe conduct to indigenous leader, understanding that cultivation is part of his identity, spirituality, and indigenous medicine

Cannabis is a plant with a long history of use, dating back thousands of years. Originally used for medicinal purposes, cannabis was later banned in many countries due to its psychoactive effects. However, in recent years, cannabis has been increasingly accepted as an effective and safe medicinal substance.

Delegates highlight the importance of bringing pharmaceutical cultivation to the country and reducing costs in the API chain

For Fritz Eduardo Kasbaum the scientific ecosystem is ready to expand, but still depends on changes in national regulation

Badger G® variety promises to boost the pharmaceutical sector and facilitate monitoring with red leaves and high CBG content

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

“Now is the time to devise strategies and discuss how to implement and improve the requirements that will come,” says Beatriz Marti Emygdio, researcher at Embrapa and president of the Permanent Committee on Cannabis (CPCAN)

Check out the confirmed names: Beatriz Marti Emygdio, Filipe Campos, Tarso Araujo, and João Paulo Silvério Perfeito will be among the specialists participating in the event in São Paulo

Parliamentarians, doctors, and associations advocated for greater access to treatments, evaluated the therapeutic potential of THC, and announced a R$ 1.25 million call for research and innovation in the sector.

Learn How to Access Cannabis Products Through the Unified Health System and Understand the Obligations of Health Insurance Providers

Cannabis

Hemp is making its way into makeup with promises of natural beauty, but still faces challenges in regulation and skin science